Trazodon
|
|
Trazodon Eigenschaften
- Schmelzpunkt:
- 86-870C
- Siedepunkt:
- 528.5±60.0 °C(Predicted)
- Dichte
- 1.3141 (rough estimate)
- Brechungsindex
- 1.5790 (estimate)
- storage temp.
- Store at -20°C
- L?slichkeit
- DMSO: 45 mg/mL (121.01 mM);Ethanol: 17 mg/mL (45.72 mM)
- Aggregatzustand
- Solid
- pka
- pKa (50% ethanol): 6.14(at 25℃)
- Farbe
- White to off-white
- Wasserl?slichkeit
- Water: Insoluble
- BCS Class
- 1
- CAS Datenbank
- 19794-93-5(CAS DataBase Reference)
- NIST chemische Informationen
- Desyrel(trazodone hcl salt)(19794-93-5)
- EPA chemische Informationen
- 1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]- (19794-93-5)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
RIDADR | 3249 | ||
---|---|---|---|
HazardClass | 6.1(b) | ||
PackingGroup | III | ||
Giftige Stoffe Daten | 19794-93-5(Hazardous Substances Data) |
Bildanzeige (GHS) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alarmwort | Warnung | ||||||||||||||
Gefahrenhinweise |
|
||||||||||||||
Sicherheit |
|
Trazodon Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Brown OilVerwenden
It is believed that trazodone, in therapeutic doses, inhibits the neuronal reuptake of serotonin. It is not a MAO inhibitor or a CNS stimulator. It has a minor influence on the reuptake of norepinephrine and dopamine. In addition, it does not bind with cholinergic or α-adrenergic receptors.Indications
Trazodone (Apothecon) is also classified as an antidepressant agent. It is a selective serotonin reuptake inhibitor (SSRI), partial agonist at postsynaptic 5-HT1A receptors, and exhibits α-adrenoceptor blocking actions.Trazodone may cause priapism and enhance libido, and it prolongs nocturnal erections. This drug has been used both orally and by intracavernosal injection. It can be used alone or in combination with yohimbine. Overall, trazodone has not been as effective in treating ED as other available agents. However, it may be an option for selected patients, particularly those with performance anxiety or low libido.
Definition
ChEBI: An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.Weltgesundheitsorganisation (WHO)
Trazodone, an antidepressant indicated for the treatment of a wide range of depressive illness, was introduced in 1973. Although it is registered for use in many countries with highly evolved regulatory authorities, approval for registration was not granted in Norway because of a suspicion of carcinogenicity in a two-year rat study.Biologische Funktion
Trazodone (Desyrel) was introduced in the early 1980s as a second-generation antidepressant. It blocks the neuronal reuptake of serotonin and is an antagonist at the 5HT2-receptor. Also, its major metabolite, mchlorophenylpiperazine (mCPP), is a postsynaptic serotonin receptor agonist. When compared to the TCAs, trazodone is relatively free of antimuscarinic side effects, but it does block the α-adrenoceptor. Common side effects include marked sedation, dizziness, orthostatic hypotension, and nausea. Priapism is an uncommon but serious side effect requiring surgical intervention in one-third of the cases reported. Because of trazodone’s sedating quality, it is often used in low doses to counter the insomnia associated with the newer antidepressants, such as the SSRIs.Clinical Use
Trazodone is a phenylpiperazine–triazolopyridine antidepressant that is structurally unrelated to most of the other antidepressant classes.Trazodone is used primarily in the treatment of insomnia, mental depression, or depression/anxiety disorders. The drug also has shown some efficacy in the treatment of benzodiazepine or alcohol dependence, diabetic neuropathy, and panic disorders.Arzneimittelwechselwirkung
Trazodone possesses serotonergic activity; therefore, the possibility of developing 5-HT syndrome should be considered in patients who are receiving trazodone and other SSRIs or serotonergic drugs concurrently. When trazodone is used concurrently with drugs metabolized by CYP3A4, caution should be used to avoid excessive sedation. Trazodone can cause hypotension, including orthostatic hypotension and syncope; concomitant administration of antihypertensive therapy may require a reduction in dosage of the antihypertensive agent.Trazodon Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Trazodon Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 126)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 |
info@tianfuchem.com | China | 21634 | 55 |
Alchem Pharmtech,Inc. | 8485655694 |
sales@alchempharmtech.com | United States | 63687 | 58 |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 |
sales@conier.com | China | 49374 | 58 |
career henan chemical co | +86-0371-86658258 +8613203830695 |
factory@coreychem.com | China | 29810 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 32161 | 58 |
Hefei TNJ Chemical Industry Co.,Ltd. | +86-0551-65418671 +8618949823763 |
sales@tnjchem.com | China | 34563 | 58 |
sgtlifesciences pvt ltd | +8617013299288 |
dj@sgtlifesciences.com | China | 12373 | 58 |
Shaanxi Didu New Materials Co. Ltd | +86-89586680 +86-13289823923 |
1026@dideu.com | China | 8670 | 58 |
LEAPCHEM CO., LTD. | +86-852-30606658 |
market18@leapchem.com | China | 43340 | 58 |
Aladdin Scientific | +1-+1(833)-552-7181 |
sales@aladdinsci.com | United States | 57505 | 58 |
19794-93-5(Trazodon)Verwandte Suche:
Propyl-3,4,5-trihydroxybenzoat
Propylbutyrat
2-[3-[4-(3-Chlorphenyl)piperazin-1-y]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-onhydrochlorid
Citalopram
Gabapentin
1-(3-Chlorphenyl)piperazindihydrochlorid
1,1-Hydrazoformamid
4-Chlorpyridin
2,4-Dichloranilin
N,N-Bis(2-hydroxyethyl)myristamid
1-(4-Chlorphenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanon
Trazodon
P-430
- 8-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-6,8,9-triazabicyclo[4.3.0]nona-2,4,9-trien-7-one
- desyrel
- Trazodone Hydrochloride 2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-1,2,4-tri
- trazon
- TRAZODONE
- trialodine
- Trazodone (base and/or unspecified salts)
- 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one
- Trazodone-d6
- 2-(3-(4-(3-chlorophenyl)piperazin-1-yl)propyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
- 1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one,2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-
- 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,5-a]pyridin-3-one
- 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one hydrochloride
- Trazodone Impurity 37
- Trazodone free base
- razodone
- Trazodone USP/EP/BP
- Trazodone tablet 50mg
- Desyrel(trazodone hcl salt)
- 2- [3- [4- (3-chlorophenyl) -1-piperazinyl] propyl] -1,2,4-triazole [4,3-a] pyridine-3 (2H) - one
- 2-(3-(4-(3-chlorophenyl)piperazin-1-yl)propyl)-[1,2,4] triazolo[4,3-a]pyridin-3(2H)-one (Trazodone)
- Trazadone HCl
- Trazodone HCl Reference Standard
- Trazodone, 10 mM in DMSO
- 19794-93-5
- 243-317-1
- C19H22ClN5O
- Trazodone
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Serotonin receptor
- Active Pharmaceutical Ingredients